Effect of clofibrate on the hepatic concentrations of citric acid cycle intermediates and malonyl-CoA in the rat
- 1 January 1981
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 28 (1) , 47-51
- https://doi.org/10.1016/0024-3205(81)90364-7
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Effects of Ethyl p-Chlorophenoxyisobutyrate on Carbohydrate and Fatty Acid Metabolism in Rat LiverThe Journal of Biochemistry, 1975
- Stimulation of hepatic triglyceride synthesis and secretion by clofibrateBiochemical and Biophysical Research Communications, 1974
- A review of studies on the mode of action of clofibrate and betabenzalbutyrateLipids, 1972
- On the Mode of Action of Lipid-lowering AgentsPublished by Elsevier ,1972
- Inhibition of hepatic triglyceride formation by clofibrateJournal of Clinical Investigation, 1971
- On the Mode of Action of Lipid-lowering AgentsJournal of Biological Chemistry, 1971
- The mechanisms underlying the hypolipidaemic effects of atromid S, nicotinic acid and benzmalecene—IBiochemical Pharmacology, 1967
- Effects of chlorophenoxyisobutyrate (CPIB) on liver composition and triglyceride synthesis in ratsJournal of Atherosclerosis Research, 1966
- Effects of α-p-chlorophenoxyisobutyryl ethyl ester (CPIB) with and without androsterone on cholesterol biosynthesis in rat liverJournal of Lipid Research, 1965
- Modification of Metabolism and Distribution of Lipids by Ethyl ChlorophenoxyisobutyrateNature, 1962